The revised PFC program in GDUFA III is “still not anywhere near where we thought we were getting … but at least I think there’s some improvement,” Fresenius Kabi’s Molly Ventrelli said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
